U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07160816) titled 'A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar' on Aug. 29.
Brief Summary: The study will look at how well insulin icodec controls blood sugar levels in participants who have never used it before. Participants with type 1 diabetes (T1D) will be treated with insulin icodec as prescribed to by their doctor, in accordance with usual clinical practice. This study will last for about 22 to 30 weeks.
Study Start Date: Sept. 01
Study Type: OBSERVATIONAL
Condition:
Diabetes Mellitus, Type 1
Intervention:
DRUG: Insulin icodec
Participants with T1D will be treated with commerciall...